Matches in SemOpenAlex for { <https://semopenalex.org/work/W1519040062> ?p ?o ?g. }
- W1519040062 endingPage "377" @default.
- W1519040062 startingPage "371" @default.
- W1519040062 abstract "cGMP enhances cAMP accumulation in platelets via cGMP-inhibited phosphodiesterase (PDE3) [Maurice and Haslam (1990) Mol. Pharmacol. 37, 671–681]. However, cGMP might also limit cAMP accumulation by activating cGMP-stimulated phosphodiesterase (PDE2). We therefore evaluated the role of PDE2 in human platelets by using erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) to inhibit this enzyme selectively. IC50 values for the inhibition of platelet PDE2 by EHNA, with 10 μM cAMP as substrate in the absence and in the presence of 1 μM cGMP, were 15 and 3 μM respectively. Changes in platelet cyclic [3H]nucleotides were measured after prelabelling with [3H]adenine and [3H]guanine. Nitroprusside (NP) caused concentration-dependent increases in [3H]cGMP and a biphasic increase in [3H]cAMP, which was maximal at 10 μM (49±6%) and smaller at 100 μM (32±6%) (means±S.E.). In the presence of EHNA (20 μM), which had no effects alone, NP caused much larger increases in platelet [3H]cAMP (125±14% at 100 μM). EHNA also enhanced [3H]cGMP accumulation at high NP concentrations. In accord with these results, EHNA markedly potentiated the inhibition of thrombin-induced platelet aggregation by NP. The roles of cAMP and cGMP in this effect were investigated by using 2´,5´-dideoxyadenosine to inhibit adenylate cyclase. This compound decreased the accumulation of [3H]cAMP but not that of [3H]cGMP, and diminished the inhibition of platelet aggregation by NP with EHNA. We conclude that much of the effect of NP with EHNA is mediated by cAMP. Lixazinone (1 μM), a selective inhibitor of PDE3, increased platelet [3H]cAMP by 177±15%. This increase in [3H]cAMP was markedly inhibited by NP; EHNA blocked this effect of NP. Parallel studies showed that NP suppressed the inhibition of platelet aggregation by lixazinone. EHNA enhanced the large increases in [3H]cAMP seen with 20 nM prostacyclin (PGI2), but had no effect with 1 nM PGI2. NP and 1 nM PGI2 acted synergistically to increase [3H]cAMP, an effect attributable to the inhibition of PDE3 by cGMP; EHNA greatly potentiated this synergism. In contrast, NP decreased the [3H]cAMP accumulation seen with 20 nM PGI2, an effect that was blocked by EHNA. The results show that, provided that cGMP is present, PDE2 plays a major role in the hydrolysis of low cAMP concentrations and restricts any increases in cAMP concentration and decreases in platelet aggregation caused by the inhibition of PDE3. At high cAMP, PDE2 plays the major role in cAMP breakdown, whether cGMP is present or not." @default.
- W1519040062 created "2016-06-24" @default.
- W1519040062 creator A5040132439 @default.
- W1519040062 creator A5056174662 @default.
- W1519040062 creator A5070218414 @default.
- W1519040062 date "1997-04-15" @default.
- W1519040062 modified "2023-10-16" @default.
- W1519040062 title "Activation of cGMP-stimulated phosphodiesterase by nitroprusside limits cAMP accumulation in human platelets: effects on platelet aggregation" @default.
- W1519040062 cites W127742586 @default.
- W1519040062 cites W1505892934 @default.
- W1519040062 cites W1558386025 @default.
- W1519040062 cites W1559386011 @default.
- W1519040062 cites W1566160921 @default.
- W1519040062 cites W1837479159 @default.
- W1519040062 cites W187129005 @default.
- W1519040062 cites W1887738321 @default.
- W1519040062 cites W1896310453 @default.
- W1519040062 cites W1923141444 @default.
- W1519040062 cites W1946101854 @default.
- W1519040062 cites W1965614591 @default.
- W1519040062 cites W1994129464 @default.
- W1519040062 cites W2001613413 @default.
- W1519040062 cites W2035179895 @default.
- W1519040062 cites W2035423234 @default.
- W1519040062 cites W2042662803 @default.
- W1519040062 cites W2044374826 @default.
- W1519040062 cites W2046549341 @default.
- W1519040062 cites W2079695285 @default.
- W1519040062 cites W2080048815 @default.
- W1519040062 cites W2104380573 @default.
- W1519040062 cites W2160234311 @default.
- W1519040062 cites W2166389885 @default.
- W1519040062 cites W2414021185 @default.
- W1519040062 cites W2417379444 @default.
- W1519040062 cites W2431464206 @default.
- W1519040062 cites W190147829 @default.
- W1519040062 doi "https://doi.org/10.1042/bj3230371" @default.
- W1519040062 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1218329" @default.
- W1519040062 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9163326" @default.
- W1519040062 hasPublicationYear "1997" @default.
- W1519040062 type Work @default.
- W1519040062 sameAs 1519040062 @default.
- W1519040062 citedByCount "79" @default.
- W1519040062 countsByYear W15190400622012 @default.
- W1519040062 countsByYear W15190400622013 @default.
- W1519040062 countsByYear W15190400622014 @default.
- W1519040062 countsByYear W15190400622015 @default.
- W1519040062 countsByYear W15190400622016 @default.
- W1519040062 countsByYear W15190400622017 @default.
- W1519040062 countsByYear W15190400622018 @default.
- W1519040062 countsByYear W15190400622019 @default.
- W1519040062 countsByYear W15190400622020 @default.
- W1519040062 countsByYear W15190400622022 @default.
- W1519040062 countsByYear W15190400622023 @default.
- W1519040062 crossrefType "journal-article" @default.
- W1519040062 hasAuthorship W1519040062A5040132439 @default.
- W1519040062 hasAuthorship W1519040062A5056174662 @default.
- W1519040062 hasAuthorship W1519040062A5070218414 @default.
- W1519040062 hasBestOaLocation W15190400622 @default.
- W1519040062 hasConcept C126322002 @default.
- W1519040062 hasConcept C134018914 @default.
- W1519040062 hasConcept C180526460 @default.
- W1519040062 hasConcept C181199279 @default.
- W1519040062 hasConcept C185592680 @default.
- W1519040062 hasConcept C2776770532 @default.
- W1519040062 hasConcept C2780069284 @default.
- W1519040062 hasConcept C2780215583 @default.
- W1519040062 hasConcept C34628245 @default.
- W1519040062 hasConcept C55493867 @default.
- W1519040062 hasConcept C58141971 @default.
- W1519040062 hasConcept C62826618 @default.
- W1519040062 hasConcept C71924100 @default.
- W1519040062 hasConcept C86803240 @default.
- W1519040062 hasConcept C89560881 @default.
- W1519040062 hasConceptScore W1519040062C126322002 @default.
- W1519040062 hasConceptScore W1519040062C134018914 @default.
- W1519040062 hasConceptScore W1519040062C180526460 @default.
- W1519040062 hasConceptScore W1519040062C181199279 @default.
- W1519040062 hasConceptScore W1519040062C185592680 @default.
- W1519040062 hasConceptScore W1519040062C2776770532 @default.
- W1519040062 hasConceptScore W1519040062C2780069284 @default.
- W1519040062 hasConceptScore W1519040062C2780215583 @default.
- W1519040062 hasConceptScore W1519040062C34628245 @default.
- W1519040062 hasConceptScore W1519040062C55493867 @default.
- W1519040062 hasConceptScore W1519040062C58141971 @default.
- W1519040062 hasConceptScore W1519040062C62826618 @default.
- W1519040062 hasConceptScore W1519040062C71924100 @default.
- W1519040062 hasConceptScore W1519040062C86803240 @default.
- W1519040062 hasConceptScore W1519040062C89560881 @default.
- W1519040062 hasIssue "2" @default.
- W1519040062 hasLocation W15190400621 @default.
- W1519040062 hasLocation W15190400622 @default.
- W1519040062 hasLocation W15190400623 @default.
- W1519040062 hasLocation W15190400624 @default.
- W1519040062 hasOpenAccess W1519040062 @default.
- W1519040062 hasPrimaryLocation W15190400621 @default.
- W1519040062 hasRelatedWork W124728163 @default.
- W1519040062 hasRelatedWork W2007897250 @default.